Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 23, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omniab, Inc.
| 1.43M |
—
|
—
| +76.76% | 3.3M |
Nov 1
| |||||||
Omniab, Inc.
| 17.98K |
$5.31 | -$98,112.87 | +0.57% | 3.17M |
Apr 7
| |||||||
Omniab, Inc.
| 243.61K |
$3.72 | $907,023.21 | +8.38% | 3.15M |
Mar 27
| |||||||
Omniab, Inc.
| 225K |
$5.19 | $1,167,750.00 | +8.38% | 2.91M |
Mar 22
| |||||||
Omniab, Inc.
| 18.41K |
$5.54 | -$104,811.26 | +0.69% | 2.68M |
Feb 15 - Feb 16
| |||||||
Viking Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Omniab, Inc.
| 19.95K |
$6.25 | -$82,631.25 | +0.75% | 2.67M |
Jan 2
| |||||||
Omniab, Inc.
| 200K |
$5.05 | $1,010,000.00 | +8.18% | 2.65M |
Dec 12
| |||||||
Omniab, Inc.
| 17.37K |
$4.85 | -$44,542.40 | +0.72% | 2.45M |
Dec 7
| |||||||
Omniab, Inc.
| 95K |
$4.27 | $405,517.00 | +4.07% | 2.43M |
Nov 10
| |||||||
Omniab, Inc.
| 45K |
$5.48 | $246,600.00 | +1.97% | 2.33M |
Aug 14
| |||||||
Omniab, Inc.
| 115K |
$4.52 | $519,800.00 | +4.68% | 2.57M |
Jun 9
| |||||||
Omniab, Inc.
| 440K |
$3.40 | $1,496,000.00 | +22.02% | 2.44M |
May 12
| |||||||
Omniab, Inc.
| 109.38K |
—
|
—
| +5.79% | 2M |
Apr 7
| |||||||
Omniab, Inc.
| -17.09K |
$3.80 | -$64,926.80 | -0.90% | 1.89M |
Feb 15
| |||||||
Omniab, Inc.
| 79.67K |
—
|
—
| +4.36% | 1.91M |
Jan 3
| |||||||
Viking Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Omniab, Inc.
| -11.62K |
$3.66 | -$42,543.84 | -0.63% | 1.83M |
Dec 28
| |||||||
Omniab, Inc.
| 150K |
$3.77 | $564,765.00 | +8.89% | 1.84M |
Dec 12
| |||||||
Omniab, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 7
| |||||||
Omniab, Inc.
| -17.27K |
$3.35 | -$57,841.10 | -1.01% | 1.69M |
Dec 1
| |||||||
Omniab, Inc.
| 300K |
$3.39 | $1,016,340.00 | +21.35% | 1.71M |
Nov 30
| |||||||
Omniab, Inc.
| 100K |
$2.76 | $276,160.00 | +7.66% | 1.41M |
Nov 9
| |||||||
Omniab, Inc.
| 1.31M |
—
|
—
|
∞
| 1.31M |
Nov 1
| |||||||
Omniab Operations, Inc.
| -186.17K |
—
|
—
| -100.00% |
0
|
Nov 1
| |||||||
Ligand Pharmaceuticals Inc
| -20.30K |
—
|
—
| -11.13% | 162.19K |
Nov 1
| |||||||
Omniab, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Omniab, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Ligand Pharmaceuticals Inc
| 9.14K |
—
|
—
| +5.27% | 182.49K |
Jun 10
| |||||||
Ligand Pharmaceuticals Inc
| 2.5K |
$82.76 | $206,909.50 | +1.46% | 173.35K |
May 13
| |||||||
Ligand Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
May 5
| |||||||
Viking Therapeutics, Inc.
| 45K |
$2.47 | $111,195.00 | +67.92% | 111.25K |
May 2
| |||||||
Viking Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Viking Therapeutics, Inc.
| 20K |
$5.69 | $113,800.00 | +43.24% | 66.25K |
Jun 10
| |||||||
Viking Therapeutics, Inc.
| 20K |
$1.50 | $30,000.00 | +76.19% | 46.25K |
Mar 22
| |||||||
Viking Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 4
| |||||||
Viking Therapeutics, Inc.
| -13.00K |
$7.35 | -$95,550.00 | -33.12% | 26.25K |
Jun 30
| |||||||
Ritter Pharmaceuticals Inc
| 115.38K |
—
|
—
| +496.25% | 138.63K |
Jan 21 - Apr 10
| |||||||
Ritter Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 15
| |||||||
Viking Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.